Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Stem Cells | 3 | 2017 | 161 | 1.090 |
Why?
|
| Neuroblastoma | 3 | 2017 | 395 | 0.990 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2017 | 126 | 0.660 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2017 | 32 | 0.590 |
Why?
|
| Transcriptome | 4 | 2018 | 628 | 0.580 |
Why?
|
| Sulfoxides | 1 | 2017 | 6 | 0.580 |
Why?
|
| Gene Expression Profiling | 5 | 2017 | 1429 | 0.580 |
Why?
|
| Genes, myc | 1 | 2017 | 39 | 0.570 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2015 | 299 | 0.520 |
Why?
|
| Pyrimidines | 1 | 2017 | 373 | 0.470 |
Why?
|
| Porphobilinogen Synthase | 1 | 2012 | 4 | 0.430 |
Why?
|
| Genomics | 2 | 2017 | 761 | 0.420 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 308 | 0.410 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2012 | 100 | 0.410 |
Why?
|
| Immunotherapy | 2 | 2017 | 669 | 0.390 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 188 | 0.390 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 1265 | 0.390 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2015 | 792 | 0.380 |
Why?
|
| Hematologic Neoplasms | 1 | 2013 | 342 | 0.330 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 1241 | 0.300 |
Why?
|
| Cell Line, Tumor | 5 | 2017 | 2553 | 0.300 |
Why?
|
| Risk | 3 | 2017 | 657 | 0.290 |
Why?
|
| Promoter Regions, Genetic | 4 | 2013 | 956 | 0.260 |
Why?
|
| Transcription Factors | 2 | 2013 | 1652 | 0.260 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 2412 | 0.260 |
Why?
|
| Gene Silencing | 2 | 2017 | 178 | 0.220 |
Why?
|
| Prognosis | 3 | 2017 | 3776 | 0.220 |
Why?
|
| Pituitary Hormones | 1 | 2002 | 7 | 0.210 |
Why?
|
| Adrenocortical Hyperfunction | 1 | 2002 | 6 | 0.210 |
Why?
|
| Cushing Syndrome | 1 | 2002 | 24 | 0.210 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2002 | 131 | 0.210 |
Why?
|
| Cardiomegaly | 2 | 2012 | 120 | 0.190 |
Why?
|
| Homeodomain Proteins | 2 | 2017 | 556 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2012 | 112 | 0.190 |
Why?
|
| Circadian Rhythm | 1 | 2002 | 305 | 0.170 |
Why?
|
| Child | 5 | 2017 | 7154 | 0.170 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2012 | 447 | 0.170 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 3003 | 0.160 |
Why?
|
| Histones | 2 | 2012 | 329 | 0.160 |
Why?
|
| Mice | 9 | 2013 | 11743 | 0.150 |
Why?
|
| Acute Chest Syndrome | 1 | 2017 | 16 | 0.140 |
Why?
|
| Embryonic Stem Cells | 1 | 2017 | 80 | 0.140 |
Why?
|
| Exosomes | 1 | 2017 | 53 | 0.140 |
Why?
|
| Pharmacogenomic Testing | 1 | 2017 | 98 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2017 | 292 | 0.130 |
Why?
|
| Humans | 17 | 2018 | 89157 | 0.130 |
Why?
|
| Exons | 1 | 2017 | 451 | 0.130 |
Why?
|
| RNA Polymerase II | 2 | 2012 | 57 | 0.130 |
Why?
|
| Cell Proliferation | 3 | 2017 | 1650 | 0.130 |
Why?
|
| Animals | 10 | 2013 | 27330 | 0.130 |
Why?
|
| Protein Binding | 3 | 2013 | 1487 | 0.120 |
Why?
|
| Citric Acid | 1 | 2013 | 40 | 0.110 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2013 | 5 | 0.110 |
Why?
|
| Adiponectin | 1 | 2013 | 20 | 0.110 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2013 | 30 | 0.110 |
Why?
|
| Child, Preschool | 3 | 2017 | 3721 | 0.110 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2013 | 11 | 0.110 |
Why?
|
| Cell Separation | 1 | 2013 | 198 | 0.110 |
Why?
|
| Nucleotide Motifs | 1 | 2013 | 48 | 0.110 |
Why?
|
| Infant | 3 | 2017 | 3149 | 0.110 |
Why?
|
| Oncogene Protein v-akt | 1 | 2012 | 21 | 0.110 |
Why?
|
| Burkitt Lymphoma | 1 | 2012 | 32 | 0.110 |
Why?
|
| Apoptosis | 2 | 2017 | 1717 | 0.110 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 73 | 0.110 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2012 | 27 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2012 | 79 | 0.100 |
Why?
|
| Heparin | 1 | 2013 | 185 | 0.100 |
Why?
|
| Sirtuins | 1 | 2012 | 46 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 136 | 0.100 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 114 | 0.100 |
Why?
|
| Diet, High-Fat | 1 | 2013 | 117 | 0.100 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 229 | 0.100 |
Why?
|
| Eye | 1 | 2012 | 111 | 0.100 |
Why?
|
| Allografts | 1 | 2013 | 181 | 0.100 |
Why?
|
| Computational Biology | 1 | 2015 | 542 | 0.100 |
Why?
|
| Metabolic Syndrome | 1 | 2013 | 123 | 0.100 |
Why?
|
| Tamoxifen | 1 | 2012 | 168 | 0.100 |
Why?
|
| DNA Primers | 1 | 2012 | 543 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 481 | 0.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2013 | 158 | 0.100 |
Why?
|
| Leukemia, Myeloid | 1 | 2012 | 249 | 0.100 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2011 | 64 | 0.100 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 32 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 1402 | 0.100 |
Why?
|
| Cell Line | 2 | 2012 | 2495 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1521 | 0.090 |
Why?
|
| Signal Transduction | 4 | 2015 | 3376 | 0.090 |
Why?
|
| Software | 1 | 2015 | 665 | 0.090 |
Why?
|
| Smad2 Protein | 1 | 2010 | 20 | 0.090 |
Why?
|
| Smad3 Protein | 1 | 2010 | 23 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 890 | 0.090 |
Why?
|
| Autophagy | 1 | 2012 | 159 | 0.090 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2011 | 91 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 922 | 0.090 |
Why?
|
| Genome, Human | 1 | 2015 | 767 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 125 | 0.090 |
Why?
|
| Binding Sites | 1 | 2013 | 1117 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2013 | 427 | 0.090 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 1214 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 340 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 414 | 0.090 |
Why?
|
| Recurrence | 1 | 2013 | 1142 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2012 | 423 | 0.080 |
Why?
|
| Transplantation Conditioning | 1 | 2011 | 374 | 0.080 |
Why?
|
| Protein Methyltransferases | 1 | 2009 | 15 | 0.080 |
Why?
|
| Graft vs Host Disease | 1 | 2011 | 360 | 0.080 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2009 | 60 | 0.080 |
Why?
|
| Base Sequence | 1 | 2012 | 2327 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 1108 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 321 | 0.080 |
Why?
|
| Disease Progression | 1 | 2013 | 1488 | 0.080 |
Why?
|
| Cell Membrane | 1 | 2011 | 669 | 0.080 |
Why?
|
| Acetylation | 3 | 2013 | 132 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 726 | 0.080 |
Why?
|
| Age Factors | 1 | 2013 | 1867 | 0.080 |
Why?
|
| DNA Methylation | 2 | 2011 | 657 | 0.070 |
Why?
|
| Graft Survival | 1 | 2011 | 899 | 0.070 |
Why?
|
| Mutation | 2 | 2017 | 4137 | 0.070 |
Why?
|
| Time Factors | 2 | 2013 | 5331 | 0.070 |
Why?
|
| Algorithms | 1 | 2015 | 1875 | 0.070 |
Why?
|
| Female | 8 | 2017 | 46078 | 0.060 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 1547 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2012 | 1574 | 0.060 |
Why?
|
| Heart Failure | 1 | 2012 | 1182 | 0.050 |
Why?
|
| Pulsatile Flow | 1 | 2002 | 50 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2012 | 1990 | 0.050 |
Why?
|
| Adolescent | 3 | 2017 | 9243 | 0.050 |
Why?
|
| Risk Factors | 1 | 2013 | 5483 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2002 | 266 | 0.050 |
Why?
|
| HeLa Cells | 2 | 2012 | 511 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2013 | 3211 | 0.050 |
Why?
|
| RNA Interference | 2 | 2012 | 376 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2013 | 8217 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2012 | 794 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 887 | 0.040 |
Why?
|
| Male | 6 | 2017 | 42309 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2017 | 2011 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2017 | 2880 | 0.040 |
Why?
|
| Adult | 4 | 2017 | 26542 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 1596 | 0.040 |
Why?
|
| Autografts | 1 | 2017 | 28 | 0.040 |
Why?
|
| Epigenesis, Genetic | 2 | 2013 | 507 | 0.040 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 117 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2017 | 89 | 0.040 |
Why?
|
| Anemia, Sickle Cell | 1 | 2017 | 144 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2017 | 459 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2015 | 187 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2015 | 263 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2012 | 12 | 0.030 |
Why?
|
| U937 Cells | 1 | 2012 | 32 | 0.030 |
Why?
|
| K562 Cells | 1 | 2012 | 44 | 0.030 |
Why?
|
| Pericytes | 1 | 2012 | 13 | 0.030 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2012 | 9 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2012 | 32 | 0.030 |
Why?
|
| Ribosomal Proteins | 1 | 2012 | 45 | 0.030 |
Why?
|
| eIF-2 Kinase | 1 | 2012 | 48 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 82 | 0.030 |
Why?
|
| Leptin | 1 | 2013 | 102 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 32 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2013 | 227 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2012 | 43 | 0.030 |
Why?
|
| Young Adult | 2 | 2017 | 6294 | 0.030 |
Why?
|
| Caspases | 1 | 2012 | 155 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2012 | 195 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 65 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2012 | 85 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2012 | 261 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 114 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2012 | 138 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 266 | 0.020 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2011 | 5 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2011 | 29 | 0.020 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2011 | 15 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 371 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1709 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 373 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 452 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 524 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2011 | 159 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2012 | 470 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 290 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 841 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2010 | 56 | 0.020 |
Why?
|
| Aged | 2 | 2011 | 19119 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2013 | 353 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2010 | 45 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 695 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 388 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2864 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 982 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 221 | 0.020 |
Why?
|
| Illinois | 1 | 2011 | 473 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 698 | 0.020 |
Why?
|
| Chromatin | 1 | 2012 | 397 | 0.020 |
Why?
|
| Remission Induction | 1 | 2011 | 740 | 0.020 |
Why?
|
| Haplotypes | 1 | 2011 | 637 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 638 | 0.020 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2009 | 12 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 996 | 0.020 |
Why?
|
| Erythroid Precursor Cells | 1 | 2009 | 33 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2009 | 86 | 0.020 |
Why?
|
| Middle Aged | 2 | 2011 | 25910 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 868 | 0.020 |
Why?
|
| Arginine | 1 | 2009 | 138 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 1130 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 247 | 0.020 |
Why?
|
| Liver | 1 | 2013 | 1205 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2012 | 613 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2011 | 1534 | 0.020 |
Why?
|
| Insulin | 1 | 2013 | 1146 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1157 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 645 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2010 | 755 | 0.020 |
Why?
|
| Incidence | 1 | 2011 | 1593 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 2439 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 1310 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2012 | 1215 | 0.020 |
Why?
|
| Pregnancy | 1 | 2013 | 3011 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2017 | 9022 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 1670 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 2399 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 1764 | 0.010 |
Why?
|